MOLECULAR DYNAMICS SIMULATIONS OF THE STK630921 INTERACTIONS TO INTERLEUKIN-17A
Fransiscus Deddy Riandono, Enade Perdana Istyastono
Abstract
Open-access reader
Fransiscus Deddy Riandono, Enade Perdana Istyastono
Abstract
Open-access reader
Objective: This research aimed to investigate the stability of the STK630921-Interleukin 17A (IL-17A) complex and to predict important residues that interact during molecular dynamics simulations. Methods: Molecular docking simulations were performed, followed by molecular dynamics (MD) simulations and the free energy of binding calculations using YASARA-Structure. The identification of interacting residues was done using PyPLIF HIPPOS. Molecular docking simulations were performed on the IL-17A binding pocket with the compound 4-[({N-[(4-Oxo-3,4-dihydro-1-phthalazinyl) acetyl] alanyl} amino) methyl] cyclohexane carboxylic acid or known as STK630921. The best-docked pose was selected for the 50 ns MD simulations production run. The MD simulations snapshots were then analyzed to see the stability of IL-17A and for the identification of interacting residues, followed by Molecular Mechanics/Poisson–Boltzmann and surface area (MM/PBSA) analysis for the free energy of binding calculations. Results: STK630921 is relatively able to stabilize IL-17A. Important interaction residues identified during the MD simulations were: Thr35(A), Pro37(A), Tyr62(A), Pro63(A)(B), Ile66(A)(B), Trp67(A), Ile96(A)(B), Val98(A)(B) and Val117(A)(B). Conclusion: STK630921 disrupts the interaction of IL-17A to its receptor by binding and stabilizing IL17A.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: This research aimed to investigate the stability of the STK630921-Interleukin 17A (IL-17A) complex and to predict important residues that interact during molecular dynamics simulations. Methods: Molecular docking simulations were performed, followed by molecular dynamics (MD) simulations and the free energy of binding calculations using YASARA-Structure. The identification of interacting residues was done using PyPLIF HIPPOS. Molecular docking simulations were performed on the IL-17A binding pocket with the compound 4-[({N-[(4-Oxo-3,4-dihydro-1-phthalazinyl) acetyl] alanyl} amino) methyl] cyclohexane carboxylic acid or known as STK630921. The best-docked pose was selected for the 50 ns MD simulations production run. The MD simulations snapshots were then analyzed to see the stability of IL-17A and for the identification of interacting residues, followed by Molecular Mechanics/Poisson–Boltzmann and surface area (MM/PBSA) analysis for the free energy of binding calculations. Results: STK630921 is relatively able to stabilize IL-17A. Important interaction residues identified during the MD simulations were: Thr35(A), Pro37(A), Tyr62(A), Pro63(A)(B), Ile66(A)(B), Trp67(A), Ile96(A)(B), Val98(A)(B) and Val117(A)(B). Conclusion: STK630921 disrupts the interaction of IL-17A to its receptor by binding and stabilizing IL17A.
Key concepts: Molecular dynamics, Molecular mechanics, Chemistry, Docking (animal), Computational chemistry, Binding energy, Amino acid residue, Interaction energy